Articles From: Belden Reports Record Revenues in the Third Quarter 2014 to Bellicum Pharmaceuticals Prices Initial Public Offering of 7,350,000 Shares of Common Stock


Belden Inc. (NYSE: BDC), a global leader in high quality, end-to-end signal transmission solutions for mission-critical applications, today reported fiscal third quarter 2014 results for the period ended September 28, 2014.
Sign-up for Belden Reports Record Revenues in the Third Quarter 2014 investment picks
Belden Inc. (NYSE: BDC), a global leader in signal transmission solutions for mission-critical applications, today announced it has signed a definitive agreement to acquire Tripwire for $710 million in cash.
Sign-up for Belden to Acquire Tripwire, a Leader in Cybersecurity, for $710 million investment picks
Belden Inc. (NYSE: BDC), a global leader in high quality, end-to-end signal transmission solutions for mission-critical applications, will host its 2014 investor and analyst meeting today via webcast.
Sign-up for Belden to Host 2014 Virtual Investor and Analyst Meeting Today and Reaffirm Fourth Quarter and Full Year 2014 Results investment picks
Belden Inc. (NYSE: BDC), a global leader in high quality, end-to-end signal transmission solutions for mission-critical applications, will report results for the fiscal fourth quarter ended December 31, 2014, before trading begins on Thursday, February 5, 2015.
Sign-up for Belden to Report Fourth Quarter 2014 Results on February 5 investment picks
2014/12/22
eBay Enterprise , an eBay Inc .
Sign-up for Belk Renews Partnership With eBay Enterprise to Manage Customer Service investment picks
2014/11/14
This news release contains forward-looking statements.
Sign-up for Bell Canada and Bell Aliant announce approval of transaction to exchange Bell Aliant Notes for Bell Canada Debentures investment picks
2014/11/20
MONTRÉAL and HALIFAX , Nov.
Sign-up for Bell Canada and Bell Aliant complete exchange of Bell Aliant Notes for Bell Canada Debentures investment picks
2015/1/16
Bell delivering more value in mobile roaming data and faster downloads Canada NewsWire Travel Data Passes now include up to double the data for 200+ international destinations MONTREAL , Jan.
Sign-up for Bell delivering more value in mobile roaming data and faster downloads investment picks
2014/12/10
Bell Labs Prize winners selected, receiving a total of $175,000 in cash prizes and the unique opportunity to collaborate with world-renowned Bell Labs to further explore their ideas MURRAY HILL, N.J. , Dec.
Sign-up for Bell Labs Announces Winners For 2014 Prize Showcasing Innovative Ideas With The Power To Change Communications investment picks
2015/1/15
G.W.A.T.T. tool enables more comprehensive modelling of virtualization and bandwidth-draining video and gaming apps as well as greater flexibility in network evolution modelling PARIS , Jan.
Sign-up for Bell Labs updates interactive energy consumption tool to measure impact of NFV, SDN and high-bandwidth services investment picks
2015/1/20
Bell Let's Talk and Bell Aliant support Nunatsiavut Government's Going Off, Growing Strong youth program Canada NewsWire NAIN, NL , Jan.
Sign-up for Bell Let's Talk and Bell Aliant support Nunatsiavut Government's Going Off, Growing Strong youth program investment picks
2015/1/14
Bell Let's Talk and Cisco to unite students around Canada in a national conversation about mental health on Bell Let's Talk Day Canada NewsWire Clara Hughes and Michel Mpambara will lead live webcasts linking schools nationwide to encourage youth to talk about mental health MONTREAL , Jan.
Sign-up for Bell Let's Talk and Cisco to unite students around Canada in a national conversation about mental health on Bell Let's Talk Day investment picks
2015/1/5
Bell Let's Talk Day 2015 is January 28: Join the national conversation about mental health! Canada NewsWire Bell Let's Talk national spokesperson Clara Hughes again invites you to the conversation about mental health on the fifth annual Bell Let's Talk Day Michael Landsberg , Howie Mandel and Mary Walsh join Clara, Michel Mpambara and Stefie Shock on the Bell Let's Talk team Learn 5 simple ways to help end the stigma around mental illness On January 28 , talk, text, tweet and share to help grow Bell's funding for Canadian mental health Please visit Bell.ca/LetsTalk to learn more and download the toolkit MONTREAL , Jan.
Sign-up for Bell Let's Talk Day 2015 is January 28: Join the national conversation about mental health! investment picks
2015/1/21
Bell Let's Talk thanks leading Canadian organizations for their support Canada NewsWire MONTREAL , Jan.
Sign-up for Bell Let's Talk thanks leading Canadian organizations for their support investment picks
2015/1/7
Bell Let's Talk: The 5 simple ways to help fight the stigma around mental illness Canada NewsWire Developed with Dr.
Sign-up for Bell Let's Talk: The 5 simple ways to help fight the stigma around mental illness investment picks
2015/1/13
Bell one of Achievers 50 Most Engaged Workplaces™ in North America Canada NewsWire "Employee engagement is a key performance indicator for Bell, so we're extremely proud to see our efforts to create a positive and thriving workplace recognized across North America ," said Bernard le Duc, Executive Vice President, Corporate Services for Bell and BCE.
Sign-up for Bell one of Achievers 50 Most Engaged Workplaces™ in North America investment picks
2014/11/28
Continues Bell's presence within GLENTEL's national retail distribution network GLENTEL plans to continue offering consumers choice in Canadian mobile phone brands Supports Bell's strategic imperatives to accelerate wireless and improve customer service Bell accelerating wireless in Canada with leading capital investments in broadband networks and mobile service innovation GLENTEL shareholders to receive $26.50 per share in a combination of cash and BCE shares Transaction represents a premium of 121% based on the 10-day volume weighted trading average share price of GLENTEL on the TSX This news release contains forward-looking statements.
Sign-up for Bell to acquire its mobile phone distributor GLENTEL investment picks
Bell to sell 50% stake in wireless retailer GLENTEL to Rogers Canada NewsWire MONTREAL , Dec.
Sign-up for Bell to sell 50% stake in wireless retailer GLENTEL to Rogers investment picks
2014/12/22
Bellatrix Announces a Revised 2015 Capital Budget of $300 Million, Updated 2015 Production Guidance, and Achievement of 2014 Exit Rate Production Guidance Canada NewsWire TSX, NYSE: BXE CALGARY , Dec.
Sign-up for Bellatrix Announces a Revised 2015 Capital Budget of $300 Million, Updated 2015 Production Guidance, and Achievement of 2014 Exit Rate Production Guidance investment picks
2014/11/26
TSX, NYSE: BXE CALGARY , Nov.
Sign-up for Bellatrix announces lender approval of increase to its credit facilities investment picks
2014/12/1
TSX, NYSE: BXE CALGARY , Dec.
Sign-up for Bellatrix announces strategic $118 million acquisition and increased production guidance investment picks
2014/12/15
TSX, NYSE: BXE CALGARY , Dec.
Sign-up for Bellatrix announces the appointment of Daniel Lewis and Steven J. Pully to its Board of Directors investment picks
2014/11/4
TSX, NYSE: BXE CALGARY , Nov.
Sign-up for Bellatrix Exploration Ltd. Reports Record Year-to-Date Production, Funds Flow from Operations, Net Profit and Third Quarter 2014 Financial Results investment picks
2015/1/9
TSX, NYSE: BXE CALGARY , Jan.
Sign-up for Bellatrix to present at the TD Securities 2015 London Energy Conference investment picks
2015/1/9
Bellatrix to present at the TD Securities 2015 London Energy Conference Canada NewsWire TSX, NYSE: BXE CALGARY , Jan.
Sign-up for Bellatrix to present at the TD Securities 2015 London Energy Conference investment picks
Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a biopharmaceutical company focused on discovering and developing novel cellular immunotherapies, today announced the closing of its underwritten initial public offering of common stock, including the underwriters’ exercise of their option to purchase an additional 1,102,500 shares at the public offering price of $19.00 per share.
Sign-up for Bellicum Pharmaceuticals Announces Closing of Initial Public Offering and Exercise of the Underwriters’ Option investment picks
Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies, today announced that the first cohort of patients in the BP-004 trial has completed dosing with the Company’s genetically engineered donor T cells (BPX-501), after receiving a partial T depleted haplo-identical allogeneic hematopoietic stem cell transplant (haplo-HSCT). The trial in pediatric patients is evaluating whether BPX-501 T cells from partially mis-matched donors administered following HSCT are safe and can help speed immune reconstitution.
Sign-up for Bellicum Pharmaceuticals Announces Successful Dosing of First Patient Cohort With BPX-501 T Cells Following Haplo-Identical Hematopoietic Stem Cell Transplant investment picks
2014/12/18
Bellicum Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing novel cellular immunotherapies, today announced the pricing of its initial public offering of 7,350,000 shares of its common stock, an increase of 1,100,000 shares from the number of shares originally offered, at a public offering price of $19.00 per share.
Sign-up for Bellicum Pharmaceuticals Prices Initial Public Offering of 7,350,000 Shares of Common Stock investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Belden Reports Record Revenues in the Third Quarter 2014 to Bellicum Pharmaceuticals Prices Initial Public Offering of 7,350,000 Shares of Common Stock
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent